The therapeutic potential of targeting the Kir 1.1 (renal outer medullary K+ ) channel

Future Medicinal Chemistry
Birgit T Priest, Alexander Pasternak

Abstract

Kir1.1 (renal outer medullary K+) channels are potassium channels expressed almost exclusively in the kidney and play a role in the body's electrolyte and water balance. Potassium efflux through Kir1.1 compliments the role of transporters and sodium channels that are the targets of known diuretics. Consequently, loss-of-function mutations in men and rodents are associated with salt wasting and low blood pressure. On this basis, Kir1.1 inhibitors may have value in the treatment of hypertension and heart failure. Efforts to develop small molecule Kir1.1 inhibitors produced MK-7145, which entered into clinical trials. The present manuscript describes the structure-activity relationships associated with this scaffold alongside other preclinical Kir1.1 blockers.

References

Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L G Palmer, G Frindt
Sep 1, 1994·Current Opinion in Nephrology and Hypertension·B C RossierJ D Horisberger
Jan 1, 1997·Annual Review of Physiology·C G Nichols, A N Lopatin
Mar 10, 1999·The American Journal of Physiology·A H BeesleyS J White
Mar 31, 2000·Toxicology and Applied Pharmacology·H WangZ Wang
Aug 24, 2000·Chemical Research in Toxicology·V Purohit, A K Basu
Apr 9, 2001·American Journal of Physiology. Renal Physiology·C B WodaL M Satlin
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Regina Preisig-MüllerJürgen Daut
Jul 18, 2002·The Journal of Biological Chemistry·John N LorenzGary E Shull
Feb 25, 2005·American Journal of Physiology. Renal Physiology·Daniel A GrayLawrence G Palmer
Jun 11, 2005·The Journal of Pharmacology and Experimental Therapeutics·Refik KanjhanMark C Bellingham
Jun 27, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Qingshang YanTong Wang
Sep 19, 2008·American Journal of Physiology. Renal Physiology·David A SpectorJames B Wade
Mar 20, 2009·American Journal of Physiology. Renal Physiology·Heidi FodstadJean-Daniel Horisberger
Aug 27, 2009·The Journal of Comparative Neurology·Gennady DvoryanchikovNirupa Chaudhari
Jan 21, 2010·Physiological Reviews·Hiroshi HibinoYoshihisa Kurachi
Jan 14, 2012·Journal of Molecular and Cellular Cardiology·Keith D Garlid, Andrew P Halestrap
Jul 20, 2012·Circulation Research·D Brian FosterBrian O'Rourke
Oct 22, 2013·The Journal of Pharmacology and Experimental Therapeutics·Maria L GarciaAlexander Pasternak
May 10, 2012·ACS Medicinal Chemistry Letters·Haifeng TangAlexander Pasternak
Aug 17, 2014·Pflügers Archiv : European journal of physiology·Esad VucicJohn P Geibel
Mar 13, 2015·Biophysical Journal·Daniel R SwaleJerod S Denton
May 26, 2015·Expert Opinion on Therapeutic Patents·Alma MartelliVincenzo Calderone
Jul 21, 2015·ACS Medicinal Chemistry Letters·Shawn P WalshAlexander Pasternak
Aug 26, 2015·Journal of the American Heart Association·Matthew C HennJennifer S Lawton
Sep 4, 2015·Critical Care : the Official Journal of the Critical Care Forum·Alberto PalazzuoliPeter A McCullough
Dec 15, 2015·Physiological Reviews·Monique N Foster, William A Coetzee
Dec 15, 2015·American Journal of Physiology. Renal Physiology·Sujay V KharadeJerod S Denton
Jan 6, 2016·The Journal of Biological Chemistry·Ke DongTong Wang
Jan 8, 2016·American Journal of Physiology. Renal Physiology·Ryan J CorneliusSteven C Sansom
Mar 28, 2016·Bioorganic & Medicinal Chemistry Letters·Shawn P WalshAlexander Pasternak
Jul 6, 2016·European Journal of Pharmacology·Jiaguo HuangStefanie Weinfurter
Jul 20, 2016·The Journal of Pharmacology and Experimental Therapeutics·Caryn HamptonMaria L Garcia
Jul 21, 2016·ACS Medicinal Chemistry Letters·Haifeng TangAlexander Pasternak
Jan 24, 2017·Bioorganic & Medicinal Chemistry Letters·Harry R ChobanianAlexander Pasternak

❮ Previous
Next ❯

Citations

Aug 16, 2021·The Journal of Biological Chemistry·Dongfang TangZhonghua Liu

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01370655
NCT01558674

Software Mentioned

IonWorks

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.